Cargando…
Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon
BACKGROUND: Combined pegylated interferon-α and ribavirin therapy has sustained virological response (SVR) rates of 54% to 61%. Pretreatment predictors of SVR to interferon therapy have not been fully investigated yet. The current study assesses a group of chemokines that may predict treatment respo...
Autores principales: | Zekri, Abdel-Rahman N, Bahnassy, Abeer A, Mohamed, Waleed S, Alam EL-Din, Hanaa M, Shousha, Hend I, Zayed, Naglaa, Eldahshan, Dina H, Abdel-Aziz, Ashraf Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707769/ https://www.ncbi.nlm.nih.gov/pubmed/23816271 http://dx.doi.org/10.1186/1743-422X-10-218 |
Ejemplares similares
-
Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010) -
Consensus siRNA for inhibition of HCV genotype-4 replication
por: Zekri, Abdel Rahman N, et al.
Publicado: (2009) -
Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4
por: Zekri, Abdel Rahman N, et al.
Publicado: (2007) -
Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization
por: Aly, Magdy S., et al.
Publicado: (2010) -
Cancer in Africa: Is It a Genetic or Environmental Health Problem?
por: Bahnassy, Abeer A., et al.
Publicado: (2020)